NL187023C - PROCESS FOR PREPARING AN ANTIBIOTIC ACTIVE CEPHALOSPORIN COMPOUND AND A PHARMACEUTICAL PREPARATION WITH ANTIBIOTIC ACTION - Google Patents

PROCESS FOR PREPARING AN ANTIBIOTIC ACTIVE CEPHALOSPORIN COMPOUND AND A PHARMACEUTICAL PREPARATION WITH ANTIBIOTIC ACTION

Info

Publication number
NL187023C
NL187023C NLAANVRAGE7414820,A NL7414820A NL187023C NL 187023 C NL187023 C NL 187023C NL 7414820 A NL7414820 A NL 7414820A NL 187023 C NL187023 C NL 187023C
Authority
NL
Netherlands
Prior art keywords
antibiotic
preparing
pharmaceutical preparation
cephalosporin compound
action
Prior art date
Application number
NLAANVRAGE7414820,A
Other languages
Dutch (nl)
Other versions
NL7414820A (en
NL187023B (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NL7414820A publication Critical patent/NL7414820A/en
Publication of NL187023B publication Critical patent/NL187023B/en
Application granted granted Critical
Publication of NL187023C publication Critical patent/NL187023C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D501/06—Acylation of 7-aminocephalosporanic acid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
NLAANVRAGE7414820,A 1973-11-30 1974-11-13 PROCESS FOR PREPARING AN ANTIBIOTIC ACTIVE CEPHALOSPORIN COMPOUND AND A PHARMACEUTICAL PREPARATION WITH ANTIBIOTIC ACTION NL187023C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42041873A 1973-11-30 1973-11-30
US50747374A 1974-09-23 1974-09-23

Publications (3)

Publication Number Publication Date
NL7414820A NL7414820A (en) 1975-06-03
NL187023B NL187023B (en) 1990-12-03
NL187023C true NL187023C (en) 1991-05-01

Family

ID=27024839

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7414820,A NL187023C (en) 1973-11-30 1974-11-13 PROCESS FOR PREPARING AN ANTIBIOTIC ACTIVE CEPHALOSPORIN COMPOUND AND A PHARMACEUTICAL PREPARATION WITH ANTIBIOTIC ACTION

Country Status (18)

Country Link
JP (1) JPS6020393B2 (en)
AR (1) AR211234A1 (en)
CA (1) CA1041481A (en)
CH (1) CH618443A5 (en)
DD (1) DD115125A5 (en)
DE (1) DE2456528C2 (en)
DK (1) DK153154C (en)
ES (1) ES432305A1 (en)
FI (1) FI60210C (en)
FR (1) FR2253022B1 (en)
GB (1) GB1480757A (en)
HU (1) HU168823B (en)
IE (1) IE40122B1 (en)
IT (1) IT1043920B (en)
NL (1) NL187023C (en)
NO (1) NO147839C (en)
SE (1) SE432934B (en)
YU (1) YU36736B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56158790A (en) * 1980-05-14 1981-12-07 Sankyo Co Ltd Preparation of cephalosporin derivative

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2127225A1 (en) * 1970-06-12 1971-12-16 Yamanouchi Pharmaceutical Co Ltd , Tokio New process for making cephalexin
US3843639A (en) * 1973-02-08 1974-10-22 Bristol Myers Co Production of cephalexin via methoxymethyl ester

Also Published As

Publication number Publication date
CH618443A5 (en) 1980-07-31
HU168823B (en) 1976-07-28
JPS50105687A (en) 1975-08-20
AR211234A1 (en) 1977-11-15
YU310474A (en) 1981-11-13
IE40122B1 (en) 1979-03-14
GB1480757A (en) 1977-07-27
NL7414820A (en) 1975-06-03
FI330174A (en) 1975-05-31
FR2253022B1 (en) 1978-07-07
DK153154C (en) 1988-10-24
FI60210C (en) 1981-12-10
CA1041481A (en) 1978-10-31
IT1043920B (en) 1980-02-29
DE2456528C2 (en) 1986-01-16
YU36736B (en) 1984-08-31
DD115125A5 (en) 1975-09-12
FR2253022A1 (en) 1975-06-27
FI60210B (en) 1981-08-31
DK589474A (en) 1975-07-28
NO147839C (en) 1983-06-22
ES432305A1 (en) 1977-06-16
NO147839B (en) 1983-03-14
AU7550474A (en) 1976-05-20
SE7414249L (en) 1975-05-31
NL187023B (en) 1990-12-03
SE432934B (en) 1984-04-30
NO744088L (en) 1975-06-23
DE2456528A1 (en) 1975-06-05
JPS6020393B2 (en) 1985-05-21
IE40122L (en) 1975-05-30
DK153154B (en) 1988-06-20

Similar Documents

Publication Publication Date Title
NL178005C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTIBACTERIAL ACTION, AND METHOD FOR PREPARING A CEPHALOSPORINE ANTIBIOTIC.
NL950016I1 (en) A method of preparing pharmaceutical preparations with antibiotic activity, as well as a method of preparing antibiotic active cephem compounds.
NL7408985A (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH FIBRINOLYTIC ACTION.
NL175641C (en) PROCESS FOR THE PREPARATION OF A TRIENIC ANTIBIOTIC, AND FOR THE PREPARATION OF A PREPARATION CONTAINING THIS ANTIBIOTIC
NL164561C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION, AND METHOD FOR PREPARING AN AGAINST BACTERIA ACTIVE 7- (THIAZOLYLACETYLAMINO) CEPHOSPORIC ACID DERIVATIVE.
NL179924C (en) METHOD FOR PREPARING AN ANTIBIOTIC AND METHOD FOR PREPARING C.Q. MANUFACTURE OF A PHARMACEUTICAL PREPARATION WITH AN EFFICIENCY AGAINST MICRO-ORGANISMS.
NL177919C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTIBIOTIC ACTION AND METHOD FOR PREPARING ANTIBIOTIC RIFAMYCIN COMPOUNDS.
NL171587C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANACTIVITY AGAINST BACTERIA, AND METHOD FOR PREPARING AN SUITABLE ACTIVE COMPOUND.
NL7411312A (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION.
NL181483C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTIBACTERIAL ACTIVITY; METHOD FOR PREPARING AN ANTIBACTERIAL ACTIVE COMPOUND
NL176267C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION AND A CEPHALOSPORIC ACID DERIVATIVE WITH ANTI-BAKERIAL ACTION.
NL162428C (en) PROCESS FOR THE PREPARATION OF AN ANTIBIOTIC.
NL7708427A (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTIBIOTIC ACTION, FORMATED MEDICINAL PRODUCT WITH ANTIBIOTIC ACTION, AND A PROCESS FOR THE PREPARATION OF MEDICINAL COMPOUNDS RECOMMENDED AS AN ACTIVE COMPOUND IN THE SAID PREPARATION.
NL176458C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION AND PROCESS FOR PREPARING ACTIVE SUBSTANCES SUITABLE.
NL165749C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTIBIOTIC ACTION, FORMED MEDICINAL PRODUCT WITH ANTIBIOTIC ACTION AND METHOD FOR PREPARING A CEPHALOSPORINE DERIVATIVE WITH ANTIBIOTIC ACTION
NL181009C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTIBACTERIAL ACTION, AND METHOD FOR PREPARING A 7-BETA-ACYLAMINO-7-ALFA-METHOXY-3- (1-ALKYL-1H-TETRAZOL-5-YYL-THYL-THYL) CARBONIC ACID DERIVATIVE.
NL186383C (en) PROCESS FOR THE PREPARATION OF OCTAHYDROINDOLOQUINOLIZINE DERIVATIVES AND PROCESS FOR THE PREPARATION OF A VARMACEUTICAL PREPARATION PREPARATION, AND FORMED PHARMACEUTICAL PREPARATION.
NL189297C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTIBIOTIC ACTION AND PROCESS FOR PREPARING A THIENAMYCIN DERIVATIVE.
NL159111B (en) METHOD FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION AND METHOD FOR THE PREPARATION OF AN ACTIVE COMPOUND AGAINST HYPERLIPEMIA AND HYPERCHOLESTEROLEMIA.
NL187023C (en) PROCESS FOR PREPARING AN ANTIBIOTIC ACTIVE CEPHALOSPORIN COMPOUND AND A PHARMACEUTICAL PREPARATION WITH ANTIBIOTIC ACTION
NL189298C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTIBIOTIC ACTION AND PROCESS FOR PREPARING A THIENAMYCIN DERIVATIVE.
NL7408875A (en) PROCESS FOR THE PREPARATION OF ALKALIPOLYPHOSPHATE COMPLEXES WITH ANTIBIOTIC ACTION, PROCEDURE FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH SUCH ACTION AND SUCH MEDICINAL PRODUCT.
NL151994B (en) PROCESS FOR THE PREPARATION OF CEPHALOSPORINE WITH ANTIBIOTIC ACTION, PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH SUCH ACTION AND FORMED MEDICINAL PRODUCT.
NL156925B (en) PROCESS FOR THE PREPARATION OF AN ANTIBIOTIC; PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS; PREPARATIONS THEREFORE OBTAINED.
NL180507C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION AGAINST INFECTIONS; METHOD FOR PREPARING THE ACTIVE SUBSTANCES

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
V4 Discontinued because of reaching the maximum lifetime of a patent